Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 7.61% is 27% below its 5-year average of 10.36%, near the low end of its 5-year range (6.52%–14.40%).
As of the fiscal period ended Friday, June 26, 2026. 9.28% above its 12-month average of 6.97%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
7.61%
RETURN ON EQUITY (ROE) AVG TTM
6.97%
RETURN ON EQUITY (ROE) AVG 3Y
7.57%
RETURN ON EQUITY (ROE) AVG 5Y
10.36%
RETURN ON EQUITY (ROE) AVG 10Y
9.95%
RETURN ON EQUITY (ROE) AVG 15Y
10.75%
RETURN ON EQUITY (ROE) AVG 20Y
11.49%
CURRENT VS TTM AVG
+9.28%
CURRENT VS 3Y AVG
+0.59%
CURRENT VS 5Y AVG
-26.51%
CURRENT VS 10Y AVG
-23.43%
CURRENT VS 15Y AVG
-29.19%
CURRENT VS 20Y AVG
-33.74%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-41.47%
vs the sector median at left
Danaher Corporation
Market Cap
$143.23B
Return on Equity (ROE)
7.61%
TTM Avg
6.97%
3Y Avg
7.57%
5Y Avg
10.36%
Market Cap
$132.36B
Return on Equity (ROE)
21.76%
TTM Avg
8.96%
3Y Avg
15.60%
5Y Avg
19.47%
Market Cap
$131.94B
Return on Equity (ROE)
41.59%
TTM Avg
-8.30%
3Y Avg
7.76%
5Y Avg
4.45%
Market Cap
$158.42B
Return on Equity (ROE)
5.09%
TTM Avg
9.04%
3Y Avg
13.32%
5Y Avg
16.07%
Market Cap
$124.38B
Return on Equity (ROE)
17.28%
TTM Avg
15.07%
3Y Avg
13.91%
5Y Avg
13.46%
Market Cap
$120.58B
Return on Equity (ROE)
6.16%
TTM Avg
4.23%
3Y Avg
6.35%
5Y Avg
7.74%
Market Cap
$118.72B
Return on Equity (ROE)
10.41%
TTM Avg
9.71%
3Y Avg
8.51%
5Y Avg
8.44%
Market Cap
$180.65B
Return on Equity (ROE)
-27.39%
TTM Avg
19.98%
3Y Avg
21.60%
5Y Avg
19.44%
Market Cap
$104.65B
Return on Equity (ROE)
N/A
TTM Avg
-189.06%
3Y Avg
-180.53%
5Y Avg
3473.86%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $143.23B | 7.61% | 6.97% | 7.57% | 10.36% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $132.36B | 21.76% | 8.96% | 15.60% | 19.47% |
| Bristol-Myers Squibb Company (BMY)vs › | $131.94B | 41.59% | -8.30% | 7.76% | 4.45% |
| Pfizer Inc. (PFE)vs › | $158.42B | 5.09% | 9.04% | 13.32% | 16.07% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.38B | 17.28% | 15.07% | 13.91% | 13.46% |
| CVS Health Corp. (CVS)vs › | $120.58B | 6.16% | 4.23% | 6.35% | 7.74% |
| Medtronic plc (MDT)vs › | $118.72B | 10.41% | 9.71% | 8.51% | 8.44% |
| Gilead Sciences, Inc. (GILD)vs › | $180.65B | -27.39% | 19.98% | 21.60% | 19.44% |
| McKesson Corporation (MCK)vs › | $104.65B | N/A | -189.06% | -180.53% | 3473.86% |
| Stryker Corporation (SYK)vs › | $104.79B | 15.55% | 14.50% | 15.05% | 14.30% |
ROE
7.6%
ROA
4.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-26 | 7.61% |
| 2026-03-27 | 6.97% |
| 2025-12-31 | 6.88% |
| 2025-09-26 | 6.86% |
| 2025-06-27 | 6.52% |
| 2025-03-28 | 7.40% |
| 2024-12-31 | 7.87% |
| 2024-09-27 | 7.59% |
| 2024-06-28 | 8.42% |
| 2024-03-29 | 8.24% |
| 2023-12-31 | 8.91% |
| 2023-09-29 | 11.29% |
| 2023-06-30 | 12.30% |
| 2023-03-31 | 13.47% |
| 2022-12-31 | 14.39% |
| 2022-09-30 | 14.40% |
| 2022-07-01 | 13.63% |
| 2022-04-01 | 13.93% |
| 2021-12-31 | 14.24% |
| 2021-10-01 | 13.55% |
| 2021-07-02 | 13.12% |
| 2021-04-02 | 11.76% |
| 2020-12-31 | 9.17% |
| 2020-10-02 | 8.51% |
| 2020-07-03 | 8.31% |
| 2020-04-03 | 9.08% |
| 2019-12-31 | 8.45% |
| 2019-09-27 | 7.63% |
| 2019-06-28 | 7.69% |
| 2019-03-29 | 7.66% |
| 2018-12-31 | 9.40% |
| 2018-09-28 | 9.98% |
| 2018-06-29 | 9.81% |
| 2018-03-30 | 9.39% |
| 2017-12-31 | 9.45% |
| 2017-09-29 | 9.39% |
| 2017-06-30 | 8.95% |
| 2017-03-31 | 9.68% |
| 2016-12-31 | 11.10% |
| 2016-09-30 | 10.76% |
| 2016-07-01 | 14.00% |
| 2016-04-01 | 14.47% |
| 2015-12-31 | 14.17% |
| 2015-10-02 | 14.41% |
| 2015-07-03 | 10.82% |
| 2015-04-03 | 11.10% |
| 2014-12-31 | 11.11% |
| 2014-09-26 | 11.48% |
| 2014-06-27 | 11.14% |
| 2014-03-28 | 11.25% |
| 2013-12-31 | 12.04% |
| 2013-09-27 | 11.90% |
| 2013-06-28 | 12.26% |
| 2013-03-29 | 12.56% |
| 2012-12-31 | 12.58% |
| 2012-09-28 | 12.35% |
| 2012-06-29 | 12.61% |
| 2012-03-30 | 13.22% |
| 2011-12-31 | 12.85% |
| 2011-09-30 | 12.58% |
| 2011-07-01 | 13.33% |
| 2011-04-01 | 13.11% |
| 2010-12-31 | 13.08% |
| 2010-10-01 | 12.04% |
| 2010-07-02 | 10.71% |
| 2010-04-02 | 10.24% |
| 2009-12-31 | 9.90% |
| 2009-10-02 | 10.62% |
| 2009-07-03 | 11.42% |
| 2009-04-03 | 12.78% |
| 2008-12-31 | 13.43% |
| 2008-09-26 | 13.10% |
| 2008-06-27 | 14.33% |
| 2008-03-28 | 14.53% |
| 2007-12-31 | 15.08% |
| 2007-09-28 | 17.05% |
| 2007-06-29 | 15.79% |
| 2007-03-30 | 16.48% |
| 2006-12-31 | 16.89% |
| 2006-09-29 | 17.07% |
| 2006-06-30 | 17.25% |
| 2006-03-31 | 17.22% |
| 2005-12-31 | 17.67% |
| 2005-09-30 | 17.30% |
| 2005-07-01 | 17.41% |
| 2005-04-01 | 16.65% |
| 2004-12-31 | 16.15% |
| 2004-10-01 | 16.69% |
| 2004-07-02 | 15.97% |
| 2004-04-02 | 15.31% |
| 2003-12-31 | 14.72% |
| 2003-09-26 | 15.28% |
| 2003-06-27 | 15.45% |
